News

New data shows DERM, our AI skin cancer diagnosis tool, could be as accurate as clinical specialist

New data shows DERM, our AI skin cancer diagnosis tool, could be as accurate as clinical specialist

The prospective, diagnostic trial saw DERM, our AI platform, correctly identify all malignant lesions (100% sensitivity) with an average AUROC of 95.8% with 65% specificity versus 70% specificity and a 77% AUROC score demonstrated by the clinical experts. DERM, a CE marked medical device, was developed as a tool to aid clinicians in identifying 11 common skin lesion types, including melanoma.

Read More

Subscribe to our news updates

We won't spam
you, we promise.